Eli Lilly and CompanyIndianapolis, IN, United States (NYSE: LLY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Eli Lilly Financial Statements

Eli Lilly Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Eli Lilly Income Statement

  2007 2006 2005
Revenue ($ mil.) 18,633.5 15,691.0 14,645.3
Gross Profit ($ mil.) 14,384.7 12,144.5 11,171.1
Operating Income ($ mil.) 3,754.8 3,180.2 2,403.3
Total Net Income ($ mil.) 2,953.0 2,662.7 1,979.6
Diluted EPS (Net Income) 2.71 2.45 1.81
More Eli Lilly financial information

Eli Lilly Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 5,150.4 4,807.6 5,189.6
Gross Profit ($ mil.) 3,949.5 3,696.3 3,916.8
Operating Income ($ mil.) 1,174.0 1,036.0 1,020.2
Total Net Income ($ mil.) 958.8 1,064.3 854.4
Diluted EPS (Net Income) 0.88 0.97 0.78
More Eli Lilly financial information

Eli Lilly Stock Quote & Chart

10/10/08 15:06:28 EST • NYSE • 31.36 • Decreased by -1.8600 • Decreased by -5.5990 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Eli Lilly Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.38 2.61 1.24
Price/Earnings Ratio 11.87 12.12 12.92
Price/Book Ratio 3.19 2.09 1.16
Price/Cash Flow Ratio 7.27 10.29 7.69
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Eli Lilly Financial Ratios

Eli Lilly Competitive Intelligence

GlaxoSmithKline Novo Nordisk Pfizer
Annual Sales ($ mil.) 22,716.0 8,261.6 48,418.0
Employees 103,401 26,000 86,600
Market Cap ($ mil.) -- -- 127,674.4

Competitive Landscape